跳至主要内容
临床试验/NCT00482235
NCT00482235已完成2 期

A Study of MK0359 in Patients With Chronic Obstructive Pulmonary Disease (COPD)(0359-016)

Merck Sharp & Dohme LLC0 个研究点目标入组 45 人开始时间: 2002年12月1日最近更新:
适应症
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
45

研究概览

简要总结

A study to test the effect of MK0359 in lessening the symptoms of COPD as compared to salmeterol and placebo.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
40 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •You are between the ages of 40 and 75
  • •You have had a history for at least a year of COPD symptoms
  • •You have a history of smoking one pack of cigarettes per day for 10 years

排除标准

  • •You have been in a research study with an investigational drug or vaccine in the last 4 weeks.
  • •You have donated blood in the last 4 weeks.
  • •You have been hospitalized or had major surgery in the last 4 weeks
  • •You have been treated in the emergency room within the last 2 months or hospitalized within the last 3 months for your COPD symptoms
  • •You have a history of heart problems in the last 6 months
  • •You have a history of stomach problems
  • •You are unwilling to avoid grapefruit juice throughout the study

研究者

申办方类型
Industry
责任方
Sponsor

相似试验